All In Biotech

Drug Trial Radar · NCT04527484

A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

A Single-center, Randomized, Parallel, Open-label , Bioequivalence Study to Compare the Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Aug 26, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 130 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

130

Planned (sponsor's estimate)

Start

Aug 20, 2020

Primary completion

Jan 10, 2021

Study completion Mar 30, 2021

Sponsor

Sponsor type
Industry
First posted
Aug 26, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will be a single-center, randomized, parallel, open-label, single dosing bridging study in healthy subjects to evaluate bioequivalence of two formulations of SHR-1314. Subjects will be randomly assigned to the Vials group, the PFS group at a ratio of 1:1

Conditions

  • Bioequivalence

Interventions

  • SHR-1314Drug

    each group subjects will be given different formulations of SHR-1314

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC0-last: Area under the serum concentration-time curve from time zero to the last measurable concentrationTime frame: from Day1 to Day113
  2. Cmax: Observed maximum serum concentrationTime frame: from Day1 to Day113
  3. AUC0-∞: Area under the serum concentration-time curve from time zero to infinityTime frame: from Day1 to Day113

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.